Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Aurinia Pharm Ord (NASDAQ: AUPH)

$6.98 USD -$0.32 (-4.38%)
Last Price $6.98
Net Change $-0.32 (-4.38%)
Bid $6.98
Ask Price $6.99
Open Price $7.35
Previous Close Price $7.3
High Price $7.35
Low Price $6.93
Number of Trades 7,336
Volume 2,818,075
Fifty Two Week High $10.54 (2017-03-13)
Fifty Two Week Low $1.74 (2016-08-15)
Average Daily Volume 8,142,400
Share Outstanding 53,430 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $34.42
Recent Earnings $
Annual EPS $-0.68
Last Quarter EPS $
Market Capitalization $0.37B
Insider Shareholders % 0%
Annual Revenue $0B
No. Shares Outstanding 53,430
Inst. Shareholder % 16.15%
Annual Net Income $-0.02B
TTM Net Profit Margin $-12944.44
1-Year Return 147.46%
3-Year Return 105.52%
5-Year Return 256.1%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 34.419998%
Dividends per Share $
Stock Split Ratio 1-50
Beta 2.92
Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

AUPH News & Stock Updates